NOK 6.93
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2021 | -5.82 Million NOK | -14.99% |
2020 | -5.06 Million NOK | 17.53% |
2019 | -6.14 Million NOK | -146.28% |
2018 | -2.49 Million NOK | 87.39% |
2017 | -19.79 Million NOK | 55.88% |
2016 | -44.86 Million NOK | -14.08% |
2015 | -39.32 Million NOK | -51.91% |
2014 | -25.88 Million NOK | -25.37% |
2013 | -20.65 Million NOK | -50.73% |
2012 | -13.7 Million NOK | -43353.76% |
2011 | -31.52 Thousand NOK | -101.04% |
2010 | 3.02 Million NOK | 50.27% |
2009 | 2.01 Million NOK | -29.39% |
2008 | 2.85 Million NOK | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2022 Q2 | 5.08 Million NOK | 0.0% |
2021 Q2 | -2.37 Million NOK | 0.0% |
2021 FY | -5.82 Million NOK | -14.99% |
2021 Q4 | -5.82 Million NOK | 0.0% |
2020 FY | -5.06 Million NOK | 17.53% |
2020 Q4 | -5.06 Million NOK | 0.0% |
2020 Q2 | -294.27 Thousand NOK | 0.0% |
2019 Q2 | -5.06 Million NOK | 0.0% |
2019 Q4 | -6.14 Million NOK | 0.0% |
2019 FY | -6.14 Million NOK | -146.28% |
2018 Q2 | -11.9 Million NOK | 0.0% |
2018 Q4 | -2.49 Million NOK | 0.0% |
2018 FY | -2.49 Million NOK | 87.39% |
2017 Q2 | -28.55 Million NOK | 0.0% |
2017 FY | -19.79 Million NOK | 55.88% |
2017 Q4 | -19.79 Million NOK | 0.0% |
2016 Q2 | -39.8 Million NOK | 11.14% |
2016 Q1 | -44.79 Million NOK | -13.9% |
2016 Q4 | -44.86 Million NOK | -10.67% |
2016 FY | -44.86 Million NOK | -14.08% |
2016 Q3 | -40.54 Million NOK | -1.85% |
2015 Q3 | -29.85 Million NOK | -12.57% |
2015 FY | -39.32 Million NOK | -51.91% |
2015 Q2 | -26.52 Million NOK | 5.94% |
2015 Q1 | -28.19 Million NOK | -8.92% |
2015 Q4 | -39.32 Million NOK | -31.73% |
2014 FY | -25.88 Million NOK | -25.37% |
2014 Q4 | -25.88 Million NOK | -30.17% |
2014 Q3 | -19.88 Million NOK | -1.93% |
2014 Q2 | -19.51 Million NOK | -7.65% |
2014 Q1 | -18.12 Million NOK | 12.23% |
2013 Q3 | -16.81 Million NOK | -1.0% |
2013 FY | -20.65 Million NOK | -50.73% |
2013 Q4 | -20.65 Million NOK | -22.83% |
2013 Q1 | -8.01 Million NOK | 41.51% |
2013 Q2 | -16.64 Million NOK | -107.72% |
2012 FY | -13.7 Million NOK | -43353.76% |
2012 Q4 | -13.7 Million NOK | -175.51% |
2012 Q3 | -4.97 Million NOK | -48.36% |
2012 Q2 | -3.35 Million NOK | 44.75% |
2012 Q1 | -6.06 Million NOK | -19140.44% |
2011 FY | -31.52 Thousand NOK | -101.04% |
2011 Q2 | 2.18 Million NOK | 376.36% |
2011 Q4 | -31.52 Thousand NOK | -100.81% |
2011 Q3 | 3.9 Million NOK | 78.51% |
2011 Q1 | 459.01 Thousand NOK | -84.84% |
2010 FY | 3.02 Million NOK | 50.27% |
2010 Q4 | 3.02 Million NOK | 0.0% |
2009 FY | 2.01 Million NOK | -29.39% |
2008 FY | 2.85 Million NOK | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Arctic Bioscience AS | -77.55 Million NOK | 92.484% |
ArcticZymes Technologies ASA | -237.27 Million NOK | 97.543% |
BerGenBio ASA | -155.55 Million NOK | 96.253% |
Hofseth BioCare ASA | 112.89 Million NOK | 105.163% |
PCI Biotech Holding ASA | -40.86 Million NOK | 85.736% |
Thor Medical ASA | -41.28 Million NOK | 85.881% |
Ultimovacs ASA | -262.84 Million NOK | 97.782% |